4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-004523
Options or other derivatives
- Chief Medical Officer acquired 3,109,848 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Norry Elliot Chief Medical Officer | 2024-01-15 | Grant or award · Option to purchase Ordinary Shares | +2,544,432 | 2,544,432 | D | ||
| Norry Elliot Chief Medical Officer | 2024-01-15 | Grant or award · Option to purchase Ordinary Shares | +565,416 | 565,416 | D | ||
Loading xslF345X05/tm243270-6_4seq1.xml…